logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
MAP kinase p38 delta Inhibitors (IC50, Ki)
Structure
Compound Name
Standard Type
Standard Values (in nM)
DoramapimodIC50300.0 [1], 1968.0 [2]
4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazoleIC5087600000.0 [1]
TofacitinibIC5010000.0 [1]
Cyclohexanol, 4-(4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl)-, trans-IC50100000.0 [1]
Benzamide, N-[4-[2-ethyl-4-(3-methylphenyl)-5-thiazolyl]-2-pyridinyl]-IC5010000.0 [1]

References
This online resource may be cited as follows
MLA
"Quest DatabaseMAP kinase p38 delta Inhibitors (IC50, Ki)." AAT Bioquest, Inc.24 Dec2025https://www.aatbio.com/data-sets/map-kinase-p38-delta-inhibitors-ic50-ki.
APA
AAT Bioquest, Inc. (2025December 24). Quest DatabaseMAP kinase p38 delta Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/map-kinase-p38-delta-inhibitors-ic50-ki.
BibTeXEndNoteRefMan